Keli Walbert
Sales & Marketing presso HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
Profilo
Keli Walbert is currently the Chief Marketing Officer & Executive Vice President at Horizon Therapeutics Plc.
She has a graduate degree from Northwestern University and an undergraduate degree from the University of Louisville.
Posizioni attive di Keli Walbert
| Società | Posizione | Inizio |
|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Sales & Marketing | 01/01/2018 |
Formazione di Keli Walbert
| Northwestern University | Graduate Degree |
| University of Louisville | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- Keli Walbert
